Deutsch English Français

Contact

EP2274440

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP2274440

EP2274440 - MARKERS AND METHODS FOR ASSESSING AND TREATING SEVERE OR PERSISTANT ASTHMA AND TNF RELATED DISORDERS [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 01.02.2013 Database last updated on 08.10.2024
Most recent event Tooltip	01.02.2013	Application deemed to be withdrawn	published on 06.03.2013 [2013/10]
Applicant(s)	For all designated states Janssen Biotech, Inc. 800/850 Ridgeview Drive Horsham, PA 19044 / US
	[2011/44]
Former [2011/03]	For all designated states Centocor Ortho Biotech Inc. 800 Ridgeview Drive Horsham, PA 19044 / US
Inventor(s)	01 / HUANG, Chris 1523 Canterbury Lane Berwyn, PA 19312 / US
	02 / WATT, Rosemary 1306 North Tulip Drive West Chester, PA 19380 / US
	03 / BARNATHAN, Elliot 1734 Ridgeway Road Havertown, PA 19083 / US
	04 / LO, Kim, Hung 918 Grandview Drive Exton, PA 19341 / US
	[2011/13]
Former [2011/03]	01 / HUANG, Chris 1523 Canterbury Lane Berwyn PA 19312 / US
	02 / WATT, Rosemary 1306 North Tulip Drive West Chester PA 19380 / US
	03 / BARNATHAN, Elliot 1734 Ridgeway Road Havertown PA 19083 / US
	04 / LO, Kim, Hung 918 Grandview Drive Exton PA 19341 / US
Representative(s)	Goodfellow, Hugh Robin, et al Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB
	[N/P]
Former [2011/03]	Goodfellow, Hugh Robin, et al Carpmaels & Ransford One Southampton Row London WC1B 5HA / GB
Application number, filing date	09722124.6	19.03.2009
	[2011/03]
	WO2009US37611
Priority number, date	US20080037989P	19.03.2008 Original published format: US 37989 P
	[2011/03]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	WO2009117547
	Date:	24.09.2009
	Language:	EN
	[2009/39]
	Type:	A2 Application without search report
	No.:	EP2274440
	Date:	19.01.2011
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 24.09.2009 takes the place of the publication of the European patent application.
	[2011/03]
Search report(s)	International search report - published on:	US	30.12.2009
	(Supplementary) European search report - dispatched on:	EP	31.05.2011
Classification	IPC:	C12Q1/68	[2011/26]
	CPC:	C12Q1/6883 (EP,KR,US); A61P1/04 (EP); A61P11/06 (EP); A61P37/00 (EP); G01N33/15 (KR); C12Q2600/106 (EP,KR,US); (+) C12Q2600/156 (EP,KR,US); C12Q2600/172 (EP,KR,US) (-)
	Former IPC [2011/03]	C12Q1/64, C12P19/34, C07H21/04
Designated contracting states	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR [2011/03]
Title	German:	MARKER UND VERFAHREN ZUR BEURTEILUNG UND BEHANDLUNG SCHWEREN ODER DAUERHAFTEN ASTHMAS UND VON ERKRANKUNGEN IN VERBINDUNG MIT TNF	[2011/03]
	English:	MARKERS AND METHODS FOR ASSESSING AND TREATING SEVERE OR PERSISTANT ASTHMA AND TNF RELATED DISORDERS	[2011/03]
	French:	MARQUEURS ET PROCÉDÉS D'ÉVALUATION ET DE TRAITEMENT DE L'ASTHME SÉVÈRE OU PERSISTANT ET DE TROUBLES LIÉS AU TNF	[2011/03]
Entry into regional phase	19.10.2010	National basic fee paid
	19.10.2010	Search fee paid
	19.10.2010	Designation fee(s) paid
	19.10.2010	Examination fee paid
Examination procedure	19.10.2010	Examination requested [2011/03]
	23.12.2011	Amendment by applicant (claims and/or description)
	28.02.2012	Despatch of a communication from the examining division (Time limit: M06)
	11.09.2012	Application deemed to be withdrawn, date of legal effect [2013/10]
	17.10.2012	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2013/10]
Divisional application(s)	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 28.02.2012
Fees paid	Renewal fee
	15.03.2011	Renewal fee patent year 03
	14.03.2012	Renewal fee patent year 04
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[A] - TOLUSSO B ET AL, "Relationship between the tumor necrosis factor receptor II (TNF-RII) gene polymorphism and sTNF-RII plasma levels in healthy controls and in rheumatoid arthritis", HUMAN IMMUNOLOGY, NEW YORK, NY, US, (20041201), vol. 65, no. 12, doi:10.1016/J.HUMIMM.2004.06.010, ISSN 0198-8859, pages 1420 - 1426, XP004685216 [A] 1-15 * the whole document * DOI: http://dx.doi.org/10.1016/j.humimm.2004.06.010
		[A] - MASCHERETTI S ET AL, "Pharmacogenetic investigation of the TNF/TNF-receptor system in patients with chronic active Crohn's disease treated with infliximab", PHARMACOGENOMICS JOURNAL, NATURE PUBLISHING GROUP, GB, (20020101), vol. 2, no. 2, doi:10.1038/SJ/TPJ/650091, ISSN 1470-269X, pages 127 - 136, XP002522285 [A] 1-15 * the whole document * DOI: http://dx.doi.org/10.1038/SJ/TPJ/650091
		[A] - MATSUKURA H ET AL, "Genetic polymorphisms of tumour necrosis factor receptor superfamily 1A and 1B affect responses to infliximab in Japanese patients with Crohn's disease.", ALIMENTARY PHARMACOLOGY & THERAPEUTICS MAY 2008 LNKD- PUBMED:18248655, (20080130), vol. 27, no. 9, ISSN 1365-2036, pages 765 - 770, XP002637335 [A] 1-15 * the whole document * DOI: http://dx.doi.org/10.1111/J.1365-2036.2008.03630.X
		[A] - "Sequence-specific oligonucleotide (SSO) probe for Homo sapiens variation rs4149581.", dbSNP, (20060306), Database accession no. Pr004703221.1, URL: NCBI, XP002637336 [A] 14,15 * the whole document *
	International search	[Y]US2006251656 (MEADE CHRISTOPHER J M [DE], et al);
		[X] - MEYERS ET AL., "Pharmacogenetic Identification of Increased Responsiveness in Severe Asthma with anti-TNF (Golimumab) Therapy.", JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, vol. 121, no. ISS.3, page 798, URL: www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6WH4-4S0F634-26&_user=10&_rdoc=1&_fmt=&_orig=search&_sort=d&_docanchor=&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=746a349749bfe70b3a79d470a8c38f7e>), XP008143553
		[A] - LIDA ET AL., "Catalog of 300 SNPs in 23 genes encoding G-protein coupled receptors.", J HUM GENET, (2004), vol. 49, pages 194 - 208, XP008143554 DOI: http://dx.doi.org/10.1007/s10038-004-0133-8

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 35p